Continue with FacebookLooking to list your PhD opportunities? Log in here.
ovarian cancer PhD Projects, Programmes & Scholarships
We have 16 ovarian cancer PhD Projects, Programmes & Scholarships
PhD saved successfully
To investigate novel interacting drug combinations in the treatment of Ovarian Cancer
Ovarian cancer (OC), the most lethal gynaecological cancer, will result in ~13,000 deaths in the UK this year. At time of diagnosis most patients (58%)… Read more
A multimodal deep learning model to predict individual cancer patient survival probabilities
Can a deep learning framework that accommodates complex cancer ‘omics data, such as gene-expression data, with clinical phenotypic data enhance our ability to predict cancer patient survival?. Read more
New anticancer therapies based on transition metal complexes
Cancer is one of the leading causes of death around the world. Over 50% of cancer tumours are treated with platinum-based metal complexes, like cisplatin and its derivatives. Read more
Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer
One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. Read more
PhD position in genome stability and Cancer –Sept 2022
All organisms can suffer DNA double-strand breaks (DSBs), during meiosis, during DNA replication as elongating forks stall or collapse, or as a consequence of treatment with DNA damaging agents such as ionizing radiation. Read more
The role of splice variants in regulating BRCA1 function
Inheriting one mutant copy of the BReast CAncer 1 (BRCA1) gene (alongside one normal copy) is well-established as a strong risk factor for the development of breast and ovarian cancer. Read more
TARGETING MITOPHAGY TO REDUCE CHEMOTHERAPY-INDUCED PAIN
"Background. Chemotherapy-induced peripheral neuropathy (CIPN) is the most commonly reported side effect of chemotherapeutic drugs, affecting quality of life in many cancer patients. Read more
Genome Diversification in Cancer and Adaptive Immunity
Genomic instability (GI) is a hallmark of cancer that plays a central role in its initiation and development. GI can arise as a result of germline and somatic mutations that compromise a cell’s ability to accurately sense, signal or repair DNA damage. Read more
Genome Diversification in Cancer and Adaptive Immunity
Genomic instability (GI) is a hallmark of cancer that plays a central role in its initiation and development. GI can arise as a result of germline and somatic mutations that compromise a cell’s ability to accurately sense, signal or repair DNA damage. Read more
Fully funded PhD studentship in Photonics: 2D Material enhanced ATR and Raman chips for biomedical sensing applications
Fully Funded PhD Studentship for UK students. 2D Material enhanced ATR and Raman chips for biomedical sensing applications. University of Southampton - Optoelectronics Research Centre. Read more
Institute of Chemical Biology (ICB) EPSRC Centre for Doctoral Training (CDT) in Chemical Biology: Innovation for the Life Sciences
Fully funded four-year studentships available for UK and International students. The Institute of Chemical Biology (ICB) Centre for Doctoral Training (CDT) is a postgraduate training programme, which forms the heart of the ICB at Imperial College London. Read more
Fully funded PhD studentship in Photonics: Early cancer diagnostics using evanescent wave Mid-IR spectroscopy
Fully Funded PhD Studentship for UK students. Early cancer diagnostics using evanescent wave Mid-IR spectroscopy. University of Southampton - Optoelectronics Research Centre. Read more
Synthesis of New Anti-Cancer Agents and Pharmacogenomics of BRCA-mutated Cancers in the Qatar Population
The group has published on the discovery of heterocyclic quinone anti-cancer agents with specificity towards hypoxic cells associated with solid tumours… Read more
Investigating the role of USP17 in intracellular trafficking
USP17 is over-expressed in a range of primary tumours including NSCLC, breast, colorectal, cervical, ovarian and osteosarcoma and its depletion has been shown to block the growth, and migration, of cells from all these cancer types. Read more
How does paclitaxel kill cells and why do some cells evade it?
Paclitaxel (Taxol) is a microtubule-stabilizing drug widely used for the treatment of breast, ovarian and lung cancers. For many years, it was thought to kill cancer cells by inducing mitotic arrest, thus preventing proliferation. Read more
- 1
- 2